CTSO - Cytosorbents PEG Multiple
Cytosorbents is expanding the presence of CytoSorb systems in intensive care units to capture the medical equipment market. The PEG fair value filter visualizes this process, where the value of 0.00 shows the latest figure. This trend relies on insurance coverage and clinical efficacy in treating sepsis, as well as the launch of the innovative Purifi system to combat cytokine storms.
Cytosorbents (CTSO) - metric breakdowns and financial figures
- current quotes and average value forecast:
- market capitalization statistics:
- balance sheet equity data:
- business debt structure and liquidity details:
Total Debt to Equity Ratio Cytosorbents|CTSO - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital cytosorbents.com|CTSO - Company Debts|Debt to Book Value CytoSorbents Corp.|CTSO - Company Long-Term Debts|Short-Term Debt Cytosorbents|Immediate Liquidity Ratio cytosorbents.com
- earnings and market ratios statistics:
CTSO - Net Profit|Company Profit Forecast Cytosorbents|CTSO - P/E Multiple|Projected Price to Earnings cytosorbents.com|CTSO - PEG Multiple|EV/EBITDA Multiple CytoSorbents Corp.|CTSO - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Cytosorbents|CTSO - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months cytosorbents.com|CTSO - Earnings growth in current year|Expected net earnings per share growth next year Cytosorbents
Fundamental company analysis:CTSO (CytoSorbents Corp)
Cytosorbents (CTSO) dominates the biomedical blood purification segment for combating sepsis in intensive care units. The growth-adjusted P/E trend reflects the balance between market value and profit expansion. This indicator divides the P/E ratio by the annual growth rate of net income. A value below one signals that the asset is undervalued relative to its scaling. This allows for the effective identification of undervalued high-tech companies for a long-term portfolio.
Competing companies
DXCM - Price to Earnings Adjusted for Growth Rate|Penumbra Corp - Price/Earnings to Growth Multiple|PEG Multiple Novanta Photonics NOVT|HAE: Price/Earnings to Growth Multiple|inspiresleep.com - Company Value to Earnings Growth Ratio|PRCT: PEG Multiple|CNMD - Growth-Adjusted Market Cap to Net Income|PLSE (Pulse Corp) - PEG Multiple|Price/Earnings to Growth Multiple InMode MD (INMD)|Price/Earnings to Growth Multiple PMI (Picard Medical Inc)|SRDX (surmodics.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Senseonics Holdings Inc SENS|NPCE - Price/Earnings to Growth Multiple|Tactile Systems Technology Inc. - PEG Multiple|Price to Earnings Adjusted for Growth Rate SANUWAVE Health Inc|OM: PEG Multiple|Growth-Adjusted P/E Ratio ELMD|LNSR (LENSAR) - PEG Multiple|AVITA Medical Inc. (RCEL) - Growth-Adjusted Market Cap to Net Income|PEG Multiple PROF|Price/Earnings to Growth Multiple bairdmed.com BDMD|PEG Multiple EDAP (EDAP TMS)|PEG Multiple Apyx Medical Corp APYX|ICCM - Price/Earnings to Growth Ratio|LUNG: Price/Earnings to Growth Ratio|TELA (telabio.com) - Price/Earnings to Growth Multiple|Sensus - Growth-Adjusted Payback Ratio|ZYXI (Zynex, Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate electroCore Medical ECOR|Price/Earnings to Growth Ratio Vicarious Surgical Inc. (RBOT)|inspira-technologies.com (IINN) - Price to Net Income Growth Ratio|SeaStar Medical Holding Corp - Price/Earnings to Growth Multiple|PEG Multiple IRIDEX Corp IRIX|Intelligent Bio - PEG Multiple|Growth-Adjusted Market Cap to Net Income Beyond Air, Inc. XAIR|Profusa (PFSA) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio SSKN (STRATA Skin Sciences, Inc.)|Price/Earnings to Growth Ratio GlucoTrack|Price/Earnings to Growth Multiple NanoVibronix Inc. (NAOV)|PEG Multiple VERO|NUWE - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Aethlon Medical, Inc. AEMD|ASXC: Growth-Adjusted P/E Ratio|AVGR: Price/Earnings to Growth Multiple|BioSig Technologies - Company Value to Earnings Growth Ratio|CUTR: PEG Multiple|Price/Earnings to Growth Multiple knowlabs.co|Price/Earnings to Growth Multiple NARI|Price to Earnings Adjusted for Growth Rate Nevro Corp NVRO|Price/Earnings to Growth Multiple RSLS (ReShape Lifesciences)|Company Value to Earnings Growth Ratio SILK
